Faruk Arslan

Faruk Arslan

Auto-generated profile, based on publicly available information

Faruk Arslan

Department of Urology, School of Medicine, Marmara University, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2025 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
FAFaruk Arslan
Faruk Arslan
ÖAÖmer Algorabi
Ömer Algorabi
OOOnur Can Ozkan
Onur Can Ozkan
Yusuf Sait TürkanYusuf Sait Türkan
Yusuf Sait Türkan
ENErsin NAMLI
Ersin NAMLI
Tufan TarcanTufan Tarcan
Tufan Tarcan

14 February 2025 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
CSCagri Akin Sekerci
Cagri Akin Sekerci
YGYunus Emre Genc
Yunus Emre Genc
OOOnur Can Ozkan
Onur Can Ozkan
FAFaruk Arslan
Faruk Arslan
COCeyhun Ozdemiroglu
Ceyhun Ozdemiroglu
KCKamil Cam
Kamil Cam

30 June 2026 in International Neurourology Journal
Verified
Journal Article
Open access
YGYunus Emre Genc
Yunus Emre Genc
FAFaruk Arslan
Faruk Arslan
OOOnur Can Ozkan
Onur Can Ozkan
OAOsman Akyuz
Osman Akyuz
RERaziye Ergun
Raziye Ergun
CSCagri Akin Sekerci
Cagri Akin Sekerci
Purpose: Urodynamic studies (UDS) are the gold standard for evaluating pediatric lower urinary tract dysfunction (LUTD). However, previous studies have shown that the interpretation of cystometric findings may vary according to the observer’s level of experience and the criteria used for evaluation. This study aimed to investigate interobserver differences in the reporting of cystometric parameters in children with spina bifida.Methods: Patients who underwent UDS between 2020 and 2025 for neurogenic LUTD secondary to spina bifida were retrospectively reviewed. Studies that did not reach 80% agreement for compliance with good urodynamic practice standards were excluded. Detrusor overactivity (DOA) and bladder compliance were independently evaluated by 4 pediatric urologists and 3 urologists experienced in neuro-urology. Agreement was assessed using Fleiss’ kappa test.Results: A total of 100 children, including 53 females and 47 males, were included; the median age was 6.5 (range, 1–17) years. Agreement of at least 80% was reached in 86% of evaluations for DOA and 82% of evaluations for compliance. Based on the ratings of 7 observers, the Fleiss’ kappa value was 0.60 for DOA, indicating moderate agreement, and 0.46 for bladder compliance, indicating weak agreement.Conclusions: This study demonstrated substantial interobserver variation in the interpretation of UDS, even among experienced centers and observers. Because UDS are essential for the diagnosis, treatment, and follow-up of patients with spina bifida, standardized criteria are needed to improve interobserver consistency in this patient group. Multicenter prospective studies involving observers with varying levels of experience are warranted to improve concordance in UDS reporting.